Syglak Laboratories Private Limited, a active private limited company, was established on 03 December 2004 in Badlapur, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24230MH2004PTC149815. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.27 M.
It upholds a active non-compliant status. Its leadership includes Lav Kumar Vadehra (Director), Gaurav Vadehra (Director). Past directors included Gaurav Vadehra, Kishore Bhooraram Choudhary, Vishnu Shankar Gurav. It holds ₹4.36 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at F-14, Midc Kulgaon, Badlapur East, Badlapur, Maharashtra, 421503.
U24230MH2004PTC149815
149815
03 December 2004
₹0.50 M
₹0.27 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Syglak Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lav Kumar Vadehra | Director | 14 Feb 2014 | Current |
| Gaurav Vadehra | Director | 21 Jul 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 23 Aug 2016 | Past |
| Pramod Abcsdd | Director | 30 Jun 2015 | Past |
| Pramod Abcsdd | Director | 14 Oct 2011 | Past |
| Pramod Abcsdd | Director | 14 Oct 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Syglak Laboratories Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 74.53% decrease. The company also saw a substantial fall in profitability, with a 61.64% decrease in profit. The company's net worth moved up by a moderate rise of 1.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Syglak Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹43,590,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2018 | Others | ₹2.86 Cr | Open |
| 11 Feb 2013 | Syndicate Bank | ₹0.80 M | Open |
| 11 Feb 2013 | Syndicate Bank | ₹0.19 M | Open |
| 02 Mar 2012 | Syndicate Bank | ₹8.50 M | Open |
| 16 Jan 2010 | Syndicate Bank | ₹5.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Syglak Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Syglak Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syglak Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Syglak Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Syndicate Bank of Rs. 8.50 M registered on 02 Mar 2012 with Charge ID 10344797 was modified on 28 Sep 2018. was documented.
Syglak Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 28.60 M with Charge ID 100157567 was registered on 06 Feb 2018. was recorded as a recent event.
Gaurav Vadehra was appointed as a Director was appointed as a Director on 21 Jul 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
Lav Kumar Vadehra was appointed as a Director was appointed as a Director on 14 Feb 2014 & has been associated with this company since 11 years 9 months . was recorded as a recent event.
The CIN of Syglak Laboratories Private Limited is U24230MH2004PTC149815.
Syglak Laboratories Private Limited is headquartered at F-14, Midc Kulgaon, Badlapur East, Badlapur, Maharashtra, 421503.
Syglak Laboratories Private Limited was incorporated on 03 December 2004.
The current directors of Syglak Laboratories Private Limited are
The primary industry of Syglak Laboratories Private Limited is Manufacturing.
Syglak Laboratories Private Limited is unlisted.
The authorized capital of Syglak Laboratories Private Limited is ₹0.50 M, and the paid-up capital is ₹0.27 M.
The compliance status of Syglak Laboratories Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX